Glioblastoma Clinical Trials in San Antonio, TX

View the best 10 glioblastoma medical studies in San Antonio, Texas. Access promising new therapies by applying to a San Antonio-based Glioblastoma clinical trial.

Trials in San Antonio, Texas

Here are the top 9 medical studies for glioblastoma in San Antonio, Texas

LP-184

Recruiting1 awardPhase 1 & 2

This trial will measure how safe and tolerable a drug is and test its effectiveness in treating advanced solid tumors.

Debio 0123 +2 More

Chemotherapy

Recruiting1 awardPhase 1 & 2

This trial is testing a new drug called Debio 0123 combined with standard treatments for adults with aggressive brain cancer. It aims to find the best dose, ensure safety, and check if it works better than current treatments.

CHM-1101 CAR-T cells

CAR T-cell Therapy

Recruiting1 awardPhase 1

This trial tests a new cancer treatment (CHM-1101) for glioblastoma to see if it is safe & effective.

BPM31510

Recruiting1 awardPhase 2

This trial will study the effects of adding a new drug, BPM31510, to standard radiation and chemotherapy treatment for newly diagnosed glioblastoma patients.

Girentuximab

Recruiting1 awardPhase 2

This trial will look at how well an imaging scan can detect and track cancer activity in people with solid tumors.

Radiation Therapy

Radiation

Recruiting1 awardPhase 2

This trial studies how well dabrafenib and trametinib work after radiation therapy in children and young adults with a specific type of brain tumor. These drugs help stop tumor growth by blocking signals that tell the cells to multiply. Dabrafenib has been developed and tested extensively for a specific type of skin cancer, showing effectiveness both alone and when used with trametinib.

Photon Beam Radiation Therapy +2 More

Radiation Therapy

Recruiting1 awardPhase 2

This trial is studying how well two types of radiation therapy work compared to standard radiation therapy when given with temozolomide in patients with newly diagnosed glioblastoma.

Radiation Therapy +2 More

Radiation

Recruiting1 awardPhase 2

This trial is studying a combination of drugs as a potential treatment for newly diagnosed malignant glioma. The drugs being studied are veliparib, radiation therapy, and temozolomide.

Temozolomide

Alkylating agents

Recruiting0 awardsPhase 2 & 3

This trial is studying the combination of temozolomide and veliparib compared to temozolomide alone in treating patients with newly diagnosed glioblastoma multiforme.

Popular Filters

Trials With No Placebo

LP-184 for Solid Tumors

Recruiting1 awardPhase 1 & 2

San Antonio, Texas

This trial will measure how safe and tolerable a drug is and test its effectiveness in treating advanced solid tumors.

Chemotherapy

Debio 0123 + Temozolomide for Glioblastoma

Recruiting1 awardPhase 1 & 2

San Antonio, Texas

This trial is testing a new drug called Debio 0123 combined with standard treatments for adults with aggressive brain cancer. It aims to find the best dose, ensure safety, and check if it works better than current treatments.

CAR T-cell Therapy

CAR T-Cell Therapy for Glioblastoma

Recruiting1 awardPhase 1

Austin, Texas

This trial tests a new cancer treatment (CHM-1101) for glioblastoma to see if it is safe & effective.

89Zr-girentuximab PET Imaging for Cancer

Recruiting1 awardPhase 2

Austin, Texas

This trial will look at how well an imaging scan can detect and track cancer activity in people with solid tumors.

Monoclonal Antibodies

NGM707 + Pembrolizumab for Cancer

Recruiting1 awardPhase 1 & 2

San Antonio, Texas

This trial is testing a new drug called NGM707, both by itself and with another drug, Pembrolizumab. It targets patients with very advanced or spreading solid tumors. The treatment aims to boost the immune system to better fight cancer.

Tricyclic Antidepressant

Imipramine + Lomustine for Glioblastoma

Recruiting1 awardPhase 2

San Antonio, Texas

This trial is testing both surgical and non-surgical treatments to see how well they work for patients who need these types of interventions.

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

Is there any support for travel costs?

Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.

Will I know what medication I am taking?

This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.

How long do clinical trials last?

Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.

Do you verify all the trials on your website?

All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.

How quickly will I hear back from a clinical trial?

Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.